Bio-Techne Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TECH research report →
About the company
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies.
- CEO
- Kim Kelderman
- IPO
- 1989
- Employees
- 3,100
- HQ
- Minneapolis, MN, US
Price Chart
- Market Cap
- $11.09B
- P/E
- 99.76
- P/S
- 9.16
- P/B
- 5.30
- EV/EBITDA
- 43.30
- Div Yield
- 0.45%
- Gross Margin
- 64.96%
- Op Margin
- 12.70%
- Net Margin
- 9.05%
- ROE
- 5.49%
- ROIC
- 4.75%
- Revenue
- $1.22B · 5.23%
- Net Income
- $73.40M · -56.34%
- EPS
- $0.47 · -56.07%
- Op Income
- $102.25M
- FCF YoY
- 8.66%
- 52W High
- $72.16
- 52W Low
- $43.20
- 50D MA
- $53.95
- 200D MA
- $58.08
- Beta
- 1.29
- Avg Volume
- 4.40M
Get TickerSpark's AI analysis on TECH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 2, 26 | Crouse Steven C. | other | 600 |
| Jun 2, 26 | Crouse Steven C. | other | 216 |
| Jun 2, 26 | Crouse Steven C. | other | 600 |
| May 8, 26 | Herr Amy E. | other | 6,636 |
| May 8, 26 | Herr Amy E. | sell | 6,636 |
| May 8, 26 | Herr Amy E. | other | 6,636 |
| May 5, 26 | Hippel James | other | 62,000 |
| May 5, 26 | Hippel James | other | 56,955 |
| May 5, 26 | Hippel James | other | 62,000 |
| May 5, 26 | Bohnen Shane | other | 8,400 |
Our TECH coverage
Recent articles, reports, and earnings notes.
No research on TECH yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TECH report →Similar companies
Peers in the same neighborhood.